MTC's neighbour Sayona's Definitive Feasability Study is absolutely incredible news, I've never been happier to read an announcement for a company I don't hold. And this is just for the simple selling of spodumene concentrate, nearby Nemaska Lithium has proven how profitable further benificiation can be (AUD~$3.5 billion NPV).
Their ore reserve of 12Mt at 1.00% is tiny and low grade for the area yet thanks to the location the economics still strongly underpin the $70M market cap. Don't just take my word for it, the mildly positive market reaction even in the currently pessimistic battery minerals market says it all.
Cancet alone has a 15-25Mt at 1-2% exploration target not including the East extension, and the drill intercepts indicate extremely economic grades (show me anyone else in the world pulling out 3.5+% of lithium in 15m+ drill intercepts). The effect of grades and mineralisation being practically at surface on the economics will be massive, I'd be suprised if Cancet produces an NPV less than half a billion just from the easy simple selling of spodumene concentrate. Even if the exploration target is completely incorrect and falls incredibly short, that still leaves a Sayona sized deposit worth $70M. Cancet is just the start, there are so many projects MTC owns that could easily become bigger and better.
A lot of people have complained for the past year about having so many projects rather than focussing on one, but if you consider that TSX listed neighbour Nemaska has 'only' made ~7 bags from its lows to get to its $700M+ market cap, its easy to see that strategy doesn't make as much money as it could for shareholders:
If not for 'return on shareholder equity in the long term', why else are we all investing in a company?
The actions the founders are taking are in the interests of themselves ending up with hundreds of millions instead of tens of millions, and for most shareholders it will be the difference between making tens of thousands or hundreds of thousands.
- Forums
- ASX - By Stock
- MTC
- Massive turnaround imminent?
MTC
metalstech limited
Add to My Watchlist
3.85%
!
13.5¢

Massive turnaround imminent?, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $28.17M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $3.713K | 27.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 0.130 |
4 | 44619 | 0.125 |
3 | 138341 | 0.120 |
1 | 10000 | 0.100 |
1 | 10500 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 1000 | 1 |
0.140 | 18675 | 2 |
0.145 | 126965 | 4 |
0.150 | 50000 | 1 |
0.155 | 35745 | 1 |
Last trade - 14.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MTC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online